September 10, 2025

Efficacy and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome.

View Full Paper

Ask AI

Bookmark

Authors

SQS Q Qu NLN N Liu TQT J Qin

Discussion

Member takes

Implication

Retrospective analysis reveals increased IgE levels in lymphocytic variant hypereosinophilic syndrome patients, suggesting potential for targeted therapies.

Key Points

Patients with lymphocytic variant hypereosinophilic syndrome often present with significant skin involvement.
Elevated serum IgE levels were found in 75% of lymphocytic variant hypereosinophilic syndrome patients, indicating a specific immune response.
A total response rate of 92.9% was achieved in patients treated with glucocorticoids, highlighting their efficacy as a first-line therapy.
After a median follow-up of 16 months, the overall survival rate for lymphocytic variant hypereosinophilic syndrome patients was 91.7%, similar to idiopathic hypereosinophilic syndrome.

Cite This Study

Qu et al. (2025) studied this question.

synapsesocial.com/papers/68c23b8fb210217d64785409 https://doi.org/10.3760/cma.j.cn121090-20250109-00019

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis reveals increased IgE levels in lymphocytic variant hypereosinophilic syndrome patients, suggesting potential for targeted therapies.

Efficacy and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome.

Discussion

Member takes

Implication

Key Points

Cite This Study

Efficacy and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider